Healthcare
Neurocrine Biosciences (NBIX)
Neurocrine Biosciences stock analysis and opportunity scoring
$140.71
↓ -0.80%
Neurocrine Biosciences (NBIX) at a glance
Neurocrine Biosciences (NBIX) is a publicly traded company in the Healthcare - Biotechnology sector tracked by MKD Intelligence.
NBIX last traded at $154.06 as of 2026-10-03.
MKD Intelligence assigns NBIX a composite opportunity score of 46 out of 100, indicating mixed conditions across trend, momentum and volume factors.
The risk score for NBIX is 38 out of 100 (moderate), where a higher number means greater expected volatility.
Price History
High
$158.35
Low
$138.35
Period
Oct 1 - Aug 28 (24d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
No recent news available.
Upcoming Events
Data as of Oct 3
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.